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ABSTRACT
This paper presents a short overview of the diagnostics
and background of type I allergy to natural rubber latex
proteins and makes recommendations for preventing
corresponding allergic diseases in the future. These
recommendations and prevention strategies are based
on the current knowledge of latex allergy presented in
the literature and are addressed to legislative bodies;
manufacturers; directors of hospitals; those working at
nursing facilities and physicians’ and dentists’ prac-
tices; as well as to other health service employees.
Primary prevention is the focus but advice is also given
on secondary prevention. The major preventive aim is
the elimination of causative protein allergens in all latex
devices and thus, the minimization of latex-related
health problems.
Key words: allergological diagnostics, allergy, natural
rubber latex, preventive measures.
INTRODUCTION
In recent years, the widespread use of medical gloves and
other medical devices made of or containing latex,
(i.e. natural rubber latex) has induced a strong increase in
immediate-type (type I) hypersensitivity diseases, especially
among healthcare workers. The prevalence of latex sen-
sitization in this working group is in the range of 5–17%.1–6
Symptoms of latex allergy range from an itchy
skin rash, urticaria, angiedema, rhinoconjunctivitis and
asthma to anaphylactic shock. Fatal cases have also
been reported6–8 (Table 1).
To date, diagnostic criteria have often been quite
different and have not enabled a comparison of
the various groups of subjects and prevention mea-
sures. Also, job fitness evaluation criteria are often not
homogeneous.
Although recent studies have indicated that latex sen-
sitization is strongly associated with the intensity of
exposure to latex allergens (including those that are
airborne), necessary preventive measures have often not
been taken.9–13 Remarkably few healthcare employees
are aware that hypersensitivity to latex is a serious health
condition, while hospital and other health care managers
also need to be informed of this problem. In order to
standardize diagnostics and intensify primary and sec-
ondary preventive measures, we have summarized the
current information and experiences on dealing with
products containing latex and with latex-related allergies.
The ultimate goal is a total or almost total elimination of
allergens in latex medical devices.
The information is directed toward legislative bodies,
manufacturers, hospital managers, those working at nur-
sing facilities and physicians’ practices, as well as other
health service employees. In order to ensure safety in the
use of latex articles, in particular the various medical
devices, internationally accepted regulatory requirements
for biocompatibility are urgently needed. Further, harmful
substances in glove material should be at the lowest
achievable level and should be listed in the user instruc-
tions. Finally, training programs must be focused not only
on users, but also on purchasers who currently favor latex
products for economic reasons.
The following recommendations take into considera-
tion previous suggestions by different working groups
(i.e. the German interdisciplinary group ‘Natural rubber
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latex allergens’14 and the National Institute of Occupa-
tional Safety and Health (NIOSH)15) as well as our clinical
and analytical experiences.
REGULATIONS AND BACKGROUND
In order to warn people who are allergic to latex, the Food
and Drug Administration of America (FDA) has published
a rule, effective from 30 September 1998, which requires
certain labeling statements for all medical devices that
contain or have packaging that contains natural rubber
latex.16 In Germany, natural rubber latex has been classi-
fied as a sensitizer of the skin and respiratory tract.17 It has
been stipulated that employers must provide low allergen,
powder-free gloves to protect workers from exposure to
allergy-causing latex proteins. However, there is no rule
which requires that medical devices containing natural
rubber latex be labeled as such. As far as we know, this is
also true for other parts of Europe.
In an effort to reduce the residual chemical additives in
latex products, which are known to be able to cause type
IV allergy in exposed people, the label ‘hypoallergenic’
was in the past applied to distinguish such products con-
taining reduced levels of chemical additives from other
products in the market. However, such latex devices,
although labeled hypoallergenic, may contain protein
allergens and can cause type I-allergic reactions in indi-
viduals sensitized to latex. The term ‘hypoallergenic’ has
been frequently misinterpreted as being related to protein
allergy. Consequently, in the FDA final rule the use of the
claim ‘hypoallergenic’ on the labels of latex-containing
medical devices is prohibited.
Although all of the documents and regulations, pub-
lished by bodies such as NIOSH18 strongly recommend the
use of latex gloves with reduced protein content in order to
minimize the exposure to latex proteins and thus to reduce
the risk of latex allergy, as yet no maximum allowable level
has been set for proteins or protein allergens in latex
medical devices. The lack of standardized methods estab-
lished to determine water-soluble proteins and protein
allergens in latex devices as well as the lack of information
about the threshold limit values causing the allergic reac-
tions has been thought to be the major reason. According
to our recent studies, more than 95% of our examined
cases had no allergic reactions when wearing gloves with a
protein allergen level of < 2 m g/g.19
Currently, more than 70% of all latex gloves used are
powdered, mostly with cornstarch. Experimental and
clinical data have demonstrated that latex proteins
(allergens) can bind to cornstarch and that aerosolized
powder on latex gloves is allergenic and can cause
severe respiratory allergic reactions.9,13,20–22 Many studies
have indicated that powder-rich latex gloves often have
much higher protein levels (Fig. 1).23,24 Such studies have
also shown that airborne glove powder represents a
threat to individuals allergic to latex and that it is an
important agent for sensitizing individuals who were pre-
viously nonallergic.
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Table 1. Allergic and irritant glove-related diseases
Disease Pathogenesis Etiologic Agents
Allergic contact dermatitis Cell-mediated allergy Accelerators
Vulcanizers
Antioxidants
Organic pigments
Irritant contact dermatitis Mechanical effect Lubricant powder crystals
Occlusion Alkaline soaps
Associated use of disinfectants Bacterial toxins
Ethylene oxide
Irritant or pseudo-allergic urticaria Non-immunological mechanism Lubricant powder
Heat
Pressure
Contact urticaria, IgE-mediated allergy Latex proteins
protein contact dermatitis
Rhinitis, asthma IgE-mediated allergy Latex proteins
Angiedema IgE-mediated allergy Latex proteins
Anaphylactic shock IgE-mediated allergy Latex proteins
DIAGNOSTICS
Latex allergy should be suspected in anyone with cuta-
neous and conjunctival nasal and/or bronchial symptoms
during or after exposure to latex articles.
All healthcare workers and patients with the following
traits in their history should undergo allergological diag-
nosis with regard to natural rubber latex allergy: (i) a
history of incompatibility reactions to natural rubber latex
products; (ii) intensive occupational contact with allergen-
rich natural rubber latex products; (iii) frequent medical or
surgical interventions; and (iv) a history of incompatibility
reactions during surgical or medical treatment.
Evaluation of medical and occupational history
Factors predisposing individuals to latex allergy (e.g. atopy,
food allergies, allergic contact dermatitis and other skin
diseases) should be explored. Exposure to latex should also
be evaluated by investigating the individual’s type of job
and department, the duration of employment, the glove
type, and the average daily use (hours per day) and con-
sumption of latex gloves.
Registration of latex-induced allergic symptoms should
be undertaken, particularly regarding work-related skin
and respiratory reactions. The date of onset should
be recorded.
Allergy tests
Allergy tests are recommended as they are necessary for
etiologic diagnosis. They include:
1. Specific IgE for latex: the use of a well standardized
sensitive and specific test is necessary (e.g. CAP-System).
2. Prick tests with a standardized latex extract.
3. Patch tests in order to detect type IV sensitization to
rubber additives.
Other tests useful for evaluating the relationship
between occupational exposure to latex and symptoms
include:
1. Wearing test in case of urticaria or protein contact
dermatitis when the allergological tests are negative. It
should be noted, however, that this test does not facilitate
the identification of etiologic agents.
2. Peak expiratory flow monitoring in case of asthma
symptoms.
3. Occupational exposure test according to Jäger
et al.25 or specific bronchial challenges in case of res-
piratory symptoms. These should be undertaken if other
tests are negative and relevant diagnostic doubts and/or
medical-legal reasons exist.
Differential diagnosis
Patch tests with rubber additives, powder additives and
the most common antigens (e.g. European standard
series) are necessary if an individual’s history is sugges-
tive of glove-induced contact eczema (Type IV allergy).
A positive patch test is the most important criterion for
the diagnosis of allergic contact dermatitis and is needed
to differentiate it from irritant contact dermatitis.
It should be noted that subjects demonstrating type IV
allergy may have concomitant type I allergy.
RECOMMENDATIONS
Recommendations to legislative bodies and
manufacturers of rubber products
For all medical products containing natural rubber latex,
the label ‘caution: contains natural rubber latex which
may cause allergic reactions’ should be regarded as
obligatory. The term ‘hypoallergenic’ is not clearly defined
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Fig. 1 Scatterplot of protein and protein allergen levels in
26 brands of powder-free latex gloves (j, lower case letters)
and in 30 brands of powdered latex gloves (h, Arabic numer-
als). The methodology for measuring the levels of extractable
proteins is based on a modified Lowry protein assay as recom-
mended by the American Society for Testing and Materials
(D 5712–95)26 and the European Committee for Standardi-
zation (pr EN 455–3).27 The levels of extractable latex allergens
were analyzed by a competitive enzyme-linked immunosorbent
assay with CAP-system (Pharmacia, Uppsala, Sweden). The
detection limits for protein content and protein allergens were
25 m g/g rubber and 2 m g/g rubber, respectively.
and thus should be deleted because it may mislead
consumers by suggesting safety.
Extractable protein and allergen content as well as
applied methods of extraction and determination should
be included on packaging. For comparability, details of
applied procedures should also be made available on
request. Further, manufacturers should cease production
of allergen-rich natural rubber latex products.
Recommendations on the use of natural rubber
latex products in hospitals, health facilities, and
physicians’ and dentists’ practices
A number of recommendations on the use of natural
rubber latex products in hospitals, health facilities, and
physicians’ and dentists’ practices have been made. First,
non-latex gloves of high quality (accepted quality level-
value £ 1.5) should be provided if contact with infectious
material is likely. Second, in order to avoid allergic re-
actions in patients and employees who have already
been sensitized to latex, as well as to prevent new sensiti-
zations (in the above-mentioned risk groups), gloves poor
in latex allergens (< 2 m g/g) or those which are allergen-
free should be used in health facilities.
Third, conditions should be created in surgical facilities
and hospitals which enable patients allergic to natural
rubber latex to be examined and treated without risk. This
especially applies to emergency units and operating
theatres. For all patients with spina bifida, operations
should be performed in an environment free of natural
rubber latex allergens.
Fourth, training programs should be initiated for con-
cerned personnel in order to provide information on the
risk factors of latex gloves. Such programs could include
information on possible glove-induced diseases, preven-
tive measures, chosing gloves which are suitable for the
job to be undertaken, and proper-use procedures. Fifth,
high risk workers such as surgeons and nurses in operat-
ing theatres should undergo regular medical surveillance.
Finally, medical practices, hospitals and health service
institutions should elaborate upon recommendations
stating the type of gloves to be used for each activity per-
formed by staff.
Prevention measures
In order to protect medical staff from allergies to natural
rubber latex, the following primary and secondary pre-
ventive measures are necessary.
Primary prevention
The aim of primary prevention is to prevent intensive skin
contact and airway exposure to the latex allergens which
to date exist in most health service areas. Allergen-rich,
powdered natural rubber latex gloves should not be used,
given that allergologically unobjectionable alternatives
are available. Further, employees with known atopic dis-
position should avoid contact with natural rubber latex-
containing products. Non-powdered gloves with reduced
protein content are an alternative. This also applies to
patients with hand eczema.
Secondary prevention for employees
In order to protect endangered workers and enable already
sensitized ones to continue with their occupational activities,
the following measures in workplaces are indispensable:
1. Allergen-free products, particularly gloves, must be
made available to individuals suffering from allergies to
natural rubber latex or who are at a high risk.
2. Due to the risk of inhalable allergens, powdered
natural rubber latex products should not be used in the
workplace by people allergic to natural rubber latex.
3. Appropriate work practices should be used in order
to reduce reactions to latex. For example, when wearing
latex gloves, individuals should not use oil-based hand
creams or lotions unless they have been shown to reduce
latex-related problems. Also, after removing latex gloves,
hands should be washed with a mild soap and dried
thoroughly. Good housekeeping practices should be
used to remove latex-containing dust from the workplace
(as in recommendation 3 for employers).
4. Employees should take advantage of all training
courses in the use of latex products provided by their
employer.
5. If an individual develops acute symptoms of latex
allergy, he/she should immediately ensure that no further
contact with latex gloves or other latex-containing prod-
ucts is made until a physician experienced in diagnosing
latex allergy has been consulted.
6. For those individuals who suffer from latex allergies,
a number of additional precautions could be helpful.
These include avoiding areas where the powder of latex
gloves worn by other workers might be inhaled; informing
employers and health care providers of the latex allergy;
and wearing a medical alert bracelet.
7. Physicians’ instructions should be carefully followed
when dealing with allergic reactions to latex.
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Additional precautions for diagnostics, therapy and
nursing of patients
During the treatment of patients allergic to natural rubber
latex, only latex-free products should be used for diag-
nostics, therapy and nursing.
In order to avoid the sensitization to natural rubber
latex of high-risk groups (e.g. patients with spina bifida
or urogenital anomalies), diagnostics, therapy and nur-
sing should be performed with devices free of natural
rubber latex. These groups should avoid air-contaminated
rooms.
Allergologists, dermatologists, general practitioners,
surgeons, pediatricians, urologists, anesthetists, dentists,
gynecologists, obstetricians and radiologists should
routinely question their patients about allergies to natural
rubber latex prior to examinations or interventions.
Patients with an increased risk are health service staff,
employees in the rubber processing industry, patients who
have undergone several surgical interventions, spina
bifida patients, individuals with urogenital anomalies and
previous atopic disorders, as well as people frequently in
contact with gloves made of natural rubber latex. High
risk groups or individuals whose case history indicates
allergy to natural rubber latex should be consulted by an
allergologist, especially prior to surgical interventions.
Patients who have an immediate-type allergy to natural
rubber latex should be provided with an allergy certifi-
cation card containing the relevant information or, more
preferably, with an emergency bracelet (e.g. ‘Medic-Alert’
bracelet). Sensitized patients hitherto without allergic re-
actions should undergo the same procedure, although
investigation results on the course of such sensitizations do
not yet exist.
Latex-allergic patients should be informed that allergy
to natural rubber latex may be associated with a cross-
allergy to food, particularly to avocado, banana, kiwifruit
and/or sweet chestnut.
Allergen and protein contents in latex gloves
The level of extractable protein and allergen contents
varies significantly in different devices made out of natural
rubber latex. Because of the variation of production pro-
cedures, the extractable protein and allergen contents of
the same glove brand can be different on different manu-
facturing dates. We have analyzed a great number of
commercially available latex articles for their protein and
allergen contents. The results listed in Fig. 1 indicate clearly
that most powder-free gloves had remarkably low or even
undetectable levels of extractable protein and protein aller-
gens. In contrast, the majority of the powdered latex
gloves, with few exceptions, showed a much higher protein
and protein allergen content. These results also indicate
that latex gloves of different manufacturers may vary
considerably regarding the protein/allergen content. The
provision of product information regarding the protein/
allergen content of latex gloves may help hospital and
other healthcare managers in their purchasing decisions.
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